CEO of Indianapolis-based health insurer wrote to Obama on Sunday to rebut the president’s criticism that WellPoint seeks
out breast cancer patients to cancel their policies.
Indianapolis-based drugmaker Eli Lilly and Co. is on course to cut 5,500 jobs by the end of 2011 in a bid to eliminate $1
billion in annual expenses.
Elanco Animal Health chief Jeff Simmons predicts that consumers will opt for food made cheaper by using
Elanco’s productivity-enhancing drugs over pricier organic and locally grown products. But, as a hedge,
he has Elanco developing products to help organic farmers, too.
Indianapolis-based Christel House is brokering sales of in-room coffee to resorts around the country, taking a 10-percent
royalty to do so. The coffee is roasted by Indianapolis-based Copper Moon Coffee Co. and packaged in red and green bags decorated
with drawings by students at Christel House’s schools.
Clarian will become Indiana University Health early next year in a bet the IU brand carries more punch statewide and nationally.
The Carmel-based life and health insurer earned $33.9 million in the quarter, more than 38 percent higher than during the
same quarter a year earlier. Nearly all of that increase, however, was due to lower losses on investments and debt modifications.
The Indianapolis-based hospital system, which has 16 hospitals as far afield as LaPorte, Hartford City and Paoli, can
now associate with all its facilities the name of the school that trains the majority of doctors and nurses throughout the
state.
Indiana has now received nearly $50 million in federal bucks to digitize health care around the state. But the latest grant—$16
million to the Indiana Health Information Exchange—comes with specific, ambitious goals for health care providers.
Three Hoosier universities—Notre Dame, Marian and Indiana—are moving to launch programs that seek to apply MBA-style training to the unique demands of schools.
Companion Diagnostics wants to detect early warning signs of chronic diseases.
The university is hoping to find a private company to take over the 5-year-old facility, which formulated and manufactured
small batches of drugs used in clinical trials.
The February earthquake in Chile sent first-quarter profit tumbling 90 percent at Indianapolis-based property and casualty
insurer Baldwin & Lyons Inc.
The Indianapolis-based health insurer was helped in first quarter by a mild flu season, but it now expects to lose nearly
700,000 customers by year end.
Medicare actuary Richard Foster estimated the new law would raise overall health care spending by an additional $311 million
over current law—more than when he first examined the legislation in December.
The Indianapolis-based health insurer announced Tuesday afternoon it will be the first company to adopt stricter standards
on canceling
policies, which are contained in the health reform bill passed in March.
Purdue University’s decision to close the Chao Center in West Lafayette is a setback for Indiana’s effort to grow
a vibrant contract drug manufacturing sector. But it’s just the latest in a series of unexpected changes—not all for
the worse—since Indianapolis-based BioCrossroads launched a contract drug manufacturing initiative in late 2007.
Dr. Stanley Adkins is chief medical officer of Indianapolis-based AmeriVeriCR, a startup that uses software to review medical
claims for errors. With health care reform and a new, larger set of
diagnosis codes phasing in over the next few years, AmeriVeri is betting that demand for its service will increase.
Indianapolis-based health insurer trades jabs with U.S. health secretary after Reuters story claims insurer deliberately cancels
coverage for breast cancer patients.
Clarian is planning to spend $1.7 billion in the next five years on capital projects, half of that going to its downtown Indianapolis
campuses.
A proposal that would have weakened Eli Lilly and Co.’s defenses against an unwanted takeover failed to pass April 19 at the company’s annual meeting of shareholders. The proposal to remove an 80-percent approval threshold for takeover bids against the wishes of Lilly’s board received approval from shareholders owning 74 percent of Lilly’s shares. But […]
